1) Knox, LS. et al. Energy expenditure in malnourished cancer patients. Ann. Surg. 194 (2), 1983, 152-62.
2) Fredrix, EW. et al. Effect of different tumor types on resting energy expenditure. Cancer Res. 51 (22), 1991, 6138-41.
3) 三木誓雄ほか. 癌悪液質に対するIL-6をターゲットとした免疫栄養療法の腫瘍学的意義. 胆と膵. 32 (2), 2011, 165-70.
4) Radbruch, L. et al. Clinical practice guideline on cancer cachexia in advanced cancer patients with focus on refractory cachexia. European Palliative Care Research Collaborative. Available from, 2011, (http://www.cancercachexia.com/literature-watch/43_clinical-practice-guidelines-on-cancer-cachexia-in-advanced-cancer, 2018年10月閲覧).
5) 乾明夫. 癌性悪液液質の成因と治療に関する最近の進歩 : サイコオンコロジーの一分野として. 癌と化学療法. 32 (6), 2005, 743-9.
6) 蘆野吉和. がん悪液質の成因と栄養障害. 緩和医療学. 8 (4), 2006, 347-53.
8) 東口高志. "消化器がんの緩和ケア". 消化器疾患最新の治療2011-2012. 菅野健太郎ほか編. 東京, 南江堂, 2011, 67-70.
9) Seyfried, TN. "Respiratory dysfunction in cancer cells". Cancer as a metabolic disease. Seyfried, TN. ed. New Jersey, John Wiley & Sons, 2012, 73-107.